Friday, July 12, 2013 12:39:07 PM
Supply chain for your generic drugs tainted? No problem, use plant-based DNA. Labor costs too high? No problem, 3-D print your products instead. Money too controlled? No problem, buy Bitcoin anonymously. Google those in the science today journals.
As once stated by our moderator, "The nano-micelles are constructed from very low toxicity substances.They have roughly the same toxicity as water. Drink too much water and it's toxic; the same with NanoViricides materials. NanoViricide micelles are constructed from materials found normally in the metabolic process. So, the nanomicelle is broken down in much the same way. The targeting ligand does not attack human cells or animal cells. It binds to sites on virus cells that the virus uses to bind with human cells. So, in effect the nanoviricide acts as though it is a human cell and cannot bind or attack human cells."
No government entity wants to be caught by surprise in a Pandemic, not in Eurasia and not in the U.S.. Dr. Eugene Seymour asserted in Equities.com interview that "...in two weeks they can create a new drug. For example, the SARS virus...give me two weeks and I can have it..." http://www.equities.com/media-gallery/170-nanoviricides-inc?category_id=65
We are living in the "Age of Information"! Who do you know is going into this weekend without at least 10,000 shares of NNVC? I believe will be $8 by the end of this year and double digit for next, IMO.
Recent NNVC News
- NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • InvestorsHub NewsWire • 05/02/2024 02:07:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:30:41 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:44:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/01/2023 08:46:45 PM
- Clinical Trial of Broad-Spectrum Antiviral Drug NV-CoV-2 is Progressing Well, Says NanoViricides - NV-CoV-2 is Positioned to Fulfill Many Unmet Medical Needs • InvestorsHub NewsWire • 07/06/2023 03:16:37 PM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM